Paclitaxel combined with bevacizumab prolongs progression free survival in metastatic breast cancer
Results from a large, randomised clinical trial for patients with breast cancer show that those who received bevacizumab (Avastin) in combination with paclitaxel (Taxol) survived without the disease getting worse for almost twice as long as patients who received paclitaxel alone. The results were announced today at the 5th European Breast Cancer Conference (EBCC-5). ...... A total of 722 patients...Colleagues, friends gather to commemorate Nobel Laureate Axelrod
Luminaries from the fields of neuroscience and mental health will gather at the National Institutes of Health (NIH) on Monday, May 23, to celebrate the life and achievements of one of their most honored colleagues, the late Nobel Laureate Julius Axelrod, Ph.D. Dr. Axelrod, known to his friends as "Julie," spent most of his 50 years as an NIH scientist at the National Institute of Mental Health, (...HHMI researchers Richard Axel and Linda Buck win 2004 Nobel Prize
The Nobel Assembly at the Karolinska Institute announced this morning that the 2004 Nobel Prize in Physiology or Medicine was awarded to , an HHMI investigator at the Fred Hutchinson Cancer Research Center. The scientists were honored for their discoveries that clarify how the olfactory system works. ...... Axel and Buck discovered a large gene family,...